Hims & Hers, a company specializing in online health and wellness products, anno...
Merck has solidified a substantial collaboration valued at $490 million with Gin...
Novartis is effectively navigating the competition to retain its foothold in the...
The FDA has officially granted approval to Iveric Bio’s intravitreal avacincapta...
In response to the recent decision by the FDA to decline the Biogen-partnered dr...
Bristol Myers Squibb is actively working to shed light on the intricate realitie...
In a large Phase 3 trial that enrolled over 17,600 participants aged 45 and olde...
Biogen announced an agreement worth an estimated $7.3 billion to acquire Reata P...
Amgen has announced successful results from a late-stage clinical trial for its ...
Aravive has encountered a significant setback as its phase 3 clinical trial for ...
Terumo Blood and Cell Technologies have introduced the Reveos system, an automat...
Everest Medicines and Calliditas recently completed patient enrollment for the C...
AstraZeneca is undergoing significant transformations, as evidenced by a series ...
The FDA has recently taken action by issuing a Class I recall for the miniaturiz...
Quest Diagnostics has recently introduced a new blood test designed to detect ea...
Octapharma, a leading biopharmaceutical company, has achieved a significant mile...
